{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:50:40Z","timestamp":1792093840327,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jad.2026.122619","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:52:40Z","timestamp":1791820360000},"page":"122619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Augmentation strategies for intravenous ketamine in treatment-resistant depression: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"417","author":[{"given":"Reinhard","family":"Janssen-Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jithin","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda F.","family":"Al-Shamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaija","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaowei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Greenshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Jetly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Swainson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122619_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.jad.2026.122619_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313070","article-title":"Augmentative pharmacological strategies in treatment-resistant major depression: a comprehensive review","volume":"22","author":"Caldiroli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2026.122619_bb0015","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122619_bb0020","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41386-019-0480-y","article-title":"Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo\u2013control study","volume":"44","author":"Chen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122619_bb0025","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41386-019-0365-0","article-title":"Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial","volume":"44","author":"Costi","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122619_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jad.2026.122619_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115949","article-title":"Efficacy of addition of the anti-inflammatory, IV glutathione to standard ketamine IV therapy in major depressive disorder","volume":"337","author":"Eshkevari","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.122619_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.brs.2018.07.012","article-title":"Brainsway\u2122 dTMS (TMS) and Brainsway\u2122 dTMS with ketamine infusions (TMSK) in treatment-resistant depression (TRD); real life results","volume":"11","author":"Ghelber","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2026.122619_bb0045","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122619_bb0050","author":"Higgins"},{"key":"10.1016\/j.jad.2026.122619_bb0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4088\/JCP.v61n0405","article-title":"Social functioning in depression: a review","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41380-021-01200-3","article-title":"Treatment resistance in psychiatry: state of the art and new directions","volume":"27","author":"Howes","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0065","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2026.122619_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.33","article-title":"Experimental medication treatment approaches for depression","volume":"7","author":"Ionescu","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0075","first-page":"1164","article-title":"Efficacy of ketamine with and without lamotrigine in treatment-resistant depression: a preliminary report","volume":"16","author":"Joseph","year":"2023","journal-title":"Pharm. Basel Switz."},{"key":"10.1016\/j.jad.2026.122619_bb0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jad.2026.122619_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1461145709000169","article-title":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial","volume":"13","author":"Mathew","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122619_bb0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0090","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jad.2020.05.088","article-title":"The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence","volume":"274","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122619_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and Esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu039","article-title":"Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder","volume":"18","author":"Niciu","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122619_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jad.2026.122619_bb0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1176\/appi.ajp.20220216","article-title":"A novel, brief, fully automated intervention to extend the antidepressant effect of a single ketamine infusion: a randomized clinical trial","volume":"179","author":"Price","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0125","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122619_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122619_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/07067437251389090","article-title":"Ketamine, psychedelics, and psychotherapy: reframing, redefining, renaming treatment models","volume":"71","author":"Swainson","year":"2026","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.122619_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s44184-026-00226-1","article-title":"A scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression in adults","volume":"5","author":"Swainson","year":"2026","journal-title":"Npj Ment. Health Res."},{"key":"10.1016\/j.jad.2026.122619_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1415905","article-title":"Enduring effects of psychotherapy, antidepressants and their combination for depression: a systematic review and meta-analysis","volume":"15","author":"Voderholzer","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: challenges and strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2026.122619_bb0150","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale Psychiatric Hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0155","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: a randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2026.122619_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12888-018-1610-5","article-title":"The effect of CBT and its modifications for relapse prevention in major depressive disorder: a systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.122619_bb0170","first-page":"996","article-title":"Economic burden of treatment-resistant depression in privately insured U.S. patients with physical conditions","volume":"26","author":"Zhdanava","year":"2020","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.jad.2026.122619_bb0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jad.2022.02.032","article-title":"The effectiveness of repeated intravenous ketamine on subjective and objective psychosocial function in patients with treatment-resistant depression and suicidal ideation","volume":"304","author":"Zhou","year":"2022","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726014734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726014734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:34:04Z","timestamp":1792092844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726014734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":34,"alternative-id":["S0165032726014734"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122619","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmentation strategies for intravenous ketamine in treatment-resistant depression: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122619"}}